Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 9Recruiting 6Terminated 5Withdrawn 2Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2CNS 2Gastrointestinal 1Breast 1

Conditions

Brain Neoplasms 263Glioblastoma 193Glioma 159Neuroblastoma 56Central Nervous System Neoplasms 55Astrocytoma 45Carcinoma, Non-Small-Cell Lung 39Neoplasms 32Breast Neoplasms 27Oligodendroglioma 26Meningioma 23Recurrence 21Neuroma, Acoustic 21Meningeal Carcinomatosis 20Gliosarcoma 20Neoplasm Metastasis 19Neurofibromatosis 1 18Medulloblastoma 18Lung Neoplasms 15Paraganglioma 14Lymphoma 14Pheochromocytoma 13Spinal Cord Neoplasms 12Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Burkitt Lymphoma 9Pancreatic Neoplasms 8Ovarian Neoplasms 7Melanoma 7Esophageal Neoplasms 7

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Brain Diseases × CNS × Clear all
NCT04755920 2024-05-09

SGM-CBM

Leiden University Medical Center

Phase 2 Unknown
10 enrolled
CNSGastrointestinal

Brain Diseases, Brain Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00906516 2009-05-21

Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

Bradmer Pharmaceuticals Inc.

Phase 2 Unknown
60 enrolled
CNS

Brain Diseases, Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡